|
India Co-hosts OneSCD Global Partnership Launch at UNGA 81
India co-hosts the launch of OneSCD, a global partnership that advances equity and transforms Sickle Cell Disease (SCD) care. The launch takes place on the sidelines of the 81st Session of the United Nations General Assembly (UNGA 81) in New York.
OneSCD and India’s National Sickle Cell Anaemia Elimination Mission:
| Dimension | Key Details |
|---|---|
| OneSCD: Core components | Comprises population-wide screening, early diagnosis, counselling, and treatment and follow-up. |
| OneSCD: Screening focus | Population-wide screening provides for identification of affected individuals and carriers. |
| OneSCD: Equity barriers | Places particular emphasis on addressing barriers related to place of residence and socio-economic circumstances. |
| National Sickle Cell Anaemia Elimination Mission: Year of launch | Has been launched in 2023. |
| National Sickle Cell Anaemia Elimination Mission: Objective | Provides for eliminating sickle cell disease as a public health concern in India by 2047. |
| National Sickle Cell Anaemia Elimination Mission: Approach | Employs population-scale screening, early diagnosis, counselling, treatment, and systematic follow-up. |
| National Sickle Cell Anaemia Elimination Mission: Implementation | Provides for integration within existing public health systems. |
| National Sickle Cell Anaemia Elimination Mission: Guiding principle | Prioritizes equitable access to timely and continuous care. |
| Sickle Cell Disease (SCD): Nature | SCD is a hereditary genetic blood disorder. |
| Sickle Cell Disease (SCD): What it affects | Affects haemoglobin, the protein responsible for transporting oxygen in red blood cells. |
| Sickle Cell Disease (SCD): Key pathological feature | The presence of abnormal haemoglobin results in red blood cells adopting a sickle shape. |
| Sickle Cell Disease (SCD): Complications | Sickle-shaped cells may obstruct blood flow, leading to complications including anaemia and recurrent pain episodes. |